129 related articles for article (PubMed ID: 15640505)
1. Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer.
Suzuki T; Sadahiro S; Fukasawa M; Ishikawa K; Kamijo A; Yasuda S; Makuuchi H; Ohizumi Y; Murayama C
Jpn J Clin Oncol; 2004 Dec; 34(12):740-6. PubMed ID: 15640505
[TBL] [Abstract][Full Text] [Related]
2. Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Kamata H; Kamijo A; Murayama C; Akiba T; Kawada S
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1232-8. PubMed ID: 23158058
[TBL] [Abstract][Full Text] [Related]
3. Predictors of tumor downsizing and regression with preoperative radiotherapy alone and with concomitant tegafur/uracil (UFT) for resectable advanced rectal adenocarcinoma.
Sadahiro S; Suzuki T; Maeda Y; Tanaka Y; Nakamura T; Saguchi T; Yasuda S; Makuuchi H; Murayama C; Ohizumi Y
Hepatogastroenterology; 2007 Jun; 54(76):1107-12. PubMed ID: 17629049
[TBL] [Abstract][Full Text] [Related]
4. Predictive markers of chemoradiotherapy for rectal cancer: comparison of biopsy specimens taken before and about 1 week after the start of chemoradiotherapy.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Saito G; Kamijo A; Akiba T; Kawada S
Int J Clin Oncol; 2015 Dec; 20(6):1130-9. PubMed ID: 25833701
[TBL] [Abstract][Full Text] [Related]
5. [Proliferation and apoptosis before and after preoperative simultaneous radiochemotherapy of rectal carcinomas].
Tannapfel A; Nüsslein S; Katalinic A; Köckerling F; Wittekind C; Fietkau R
Strahlenther Onkol; 1998 Jun; 174(6):295-9. PubMed ID: 9645209
[TBL] [Abstract][Full Text] [Related]
6. [Predictive factors of histologic effects in preoperative radiotherapy for rectal cancer].
Suzuki T; Sadahiro S; Ishikawa K; Ishida H; Fukazawa M; Makuuchi H; Murayama C
Nihon Rinsho; 2003 Sep; 61 Suppl 7():439-43. PubMed ID: 14574931
[No Abstract] [Full Text] [Related]
7. Evaluating the combination of molecular prognostic factors in tumor radiosensitivity in rectal cancer.
Komuro Y; Watanabe T; Tsurita G; Muto T; Nagawa H
Hepatogastroenterology; 2005; 52(63):666-71. PubMed ID: 15966178
[TBL] [Abstract][Full Text] [Related]
8. Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis.
Hur H; Tulina I; Cho MS; Min BS; Koom WS; Lim JS; Ahn JB; Kim NK
Dis Colon Rectum; 2016 Dec; 59(12):1174-1182. PubMed ID: 27824703
[TBL] [Abstract][Full Text] [Related]
9. Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.
Zlobec I; Vuong T; Compton CC; Lugli A; Michel RP; Hayashi S; Jass JR
Br J Cancer; 2008 Jan; 98(2):450-6. PubMed ID: 18182986
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer.
Rödel C; Grabenbauer GG; Papadopoulos T; Bigalke M; Günther K; Schick C; Peters A; Sauer R; Rödel F
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):294-303. PubMed ID: 11872273
[TBL] [Abstract][Full Text] [Related]
11. Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy.
Shia J; Tickoo SK; Guillem JG; Qin J; Nissan A; Hoos A; Stojadinovic A; Ruo L; Wong WD; Paty PB; Weiser MR; Minsky BD; Klimstra DS
Am J Surg Pathol; 2002 Jul; 26(7):863-72. PubMed ID: 12131153
[TBL] [Abstract][Full Text] [Related]
12. Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy.
Sogawa N; Takiguchi N; Koda K; Oda K; Satomi D; Kato K; Ishikura H; Miyazaki M
Int J Oncol; 2002 Oct; 21(4):787-93. PubMed ID: 12239617
[TBL] [Abstract][Full Text] [Related]
13. The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissue.
Stift A; Prager G; Selzer E; Widder J; Kandioler D; Friedl J; Teleky B; Herbst F; Wrba F; Bergmann M
Int J Oncol; 2003 Nov; 23(5):1269-75. PubMed ID: 14532965
[TBL] [Abstract][Full Text] [Related]
14. Gender-related differences in pathological and clinical tumor response based on immunohistochemical proteins expression in rectal cancer patients treated with short course of preoperative radiotherapy.
Gasinska A; Adamczyk A; Niemiec J; Biesaga B; Darasz Z; Skolyszewski J
J Gastrointest Surg; 2014 Jul; 18(7):1306-18. PubMed ID: 24756926
[TBL] [Abstract][Full Text] [Related]
15. High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection.
Rödel F; Hoffmann J; Grabenbauer GG; Papadopoulos T; Weiss C; Günther K; Schick C; Sauer R; Rödel C
Strahlenther Onkol; 2002 Aug; 178(8):426-35. PubMed ID: 12240548
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma of the rectum. Possible cellular predictors of metastatic potential and response to radiation therapy.
Desai GR; Myerson RJ; Higashikubo R; Birnbaum E; Fleshman J; Fry R; Kodner I; Kucik N; Lacey D; Ribeiro M
Dis Colon Rectum; 1996 Oct; 39(10):1090-6. PubMed ID: 8831521
[TBL] [Abstract][Full Text] [Related]
17. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
Klenova A; Parvanova V; Georgiev R; Gesheva N
J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
[TBL] [Abstract][Full Text] [Related]
18. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.
Luna-Perez P; Arriola EL; Cuadra Y; Alvarado I; Quintero A
Ann Surg Oncol; 1998; 5(3):203-8. PubMed ID: 9607618
[TBL] [Abstract][Full Text] [Related]
19. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
Yao YF; Du CZ; Chen N; Chen P; Gu J
Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.
Engels B; Tournel K; Everaert H; Hoorens A; Sermeus A; Christian N; Storme G; Verellen D; De Ridder M
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):142-8. PubMed ID: 22014952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]